Activating SilverSneakers Benefits for Seniors With Osteoarthritis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorMilton S. Hershey Medical Center

About this trial

The aim of this pragmatic randomized controlled trial is to test the effects of a brief proactive care intervention involving mailed material and two phone calls on: (1) increasing participation in SilverSneakers exercise programs among older adults with osteoarthritis; (2) improving physical, social and psychological outcomes identified as important to older adults with osteoarthritis; and (3) reducing costly osteoarthritis-related health service use. Approximately 1,454 older adults with osteoarthritis who have SilverSneakers access through their Medicare Advantage plan, but no prior SilverSneakers use, will be recruited to participate across the United States. Key outcome measures will be assessed over a two-year follow-up period.

Eligibility criteria

Qualifiers

Aged 65 and older.

ICD-9 or ICD-10 code for hip, knee, or general osteoarthritis.

Positive response to a standardized question from the Medical Expenditure Panel Survey that asks if patient was diagnosed with osteoarthritis/arthritis and self-report confirmation of hip and/or knee pain due to their osteoarthritis/arthritis.

Continuous enrollment for at least one year in a Humana Medicare Advantage plan which provides free SilverSneakers access and both medical and prescription drug coverage.

Disqualifiers

Another person in the same household is enrolling/enrolled in the study (to prevent treatment contamination, only one participant per household can participate).

Medicare/Medicaid dual enrollment due to limited data accessibility for this group.

Receiving hospice care or under long-term institutional care (Part C) due to limited data accessibility for this group.

Receiving care from a provider credentialed through a delegated arrangement (i.e., delegated provider), due to limited data accessibility for this group.

Trial design

Treatments tested in this trial

  • Proactive Care

Treatment groups

1,454 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Milton S. Hershey Medical Center

Lead sponsor

Humana Healthcare Research

Collaborator

Kaiser Permanente

Collaborator

Global Healthy Living Foundation

Collaborator

Patient-Centered Outcomes Research Institute

Collaborator

CVS Healthspire Life Sciences Solutions

Collaborator

Tivity Health

Collaborator